Advertisement

Assessing Nutritional Requirements for Preterm Infants

  • Ian J. GriffinEmail author
Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Although the macrominerals calcium, phosphorus, and magnesium are of primary concern in bone health, other minerals, including trace minerals can also play an important role. In this chapter, the role of some of these will be considered. In general, the data supporting and defining the role of the trace minerals in bone health is much less well developed than for the macrominerals. In many cases, studies have used animal models, which are difficult to extrapolate to humans. In others, the relationship between serum levels of minerals and markers of bone health or assessment of bone mineral density are described. These are difficult to interpret, and even if a correlation between low serum copper and low bone mineral density (for example) is demonstrated this does not mean that additional dietary copper would improve bone mineral density. Such relationships are confounded by the other lifestyle and socioeconomic factors that may cause such differences in dietary intakes. In addition, low-quality diets may be deficient in more than one nutrient, making it extremely difficult to ascribe the change to any single nutrient. There are very few well-designed intervention studies in humans that address the importance of trace and ultratrace minerals in human bone metabolism. The one exception appears to be strontium, where there is increasing good-quality data (i.e. randomized controlled studies) suggesting that high-risk adults may benefit from strontium supplementation.

Keywords

Nutritional requirements for preterm infants Macrominerals Copper deficiency Zinc Boron Strontium Silicon Trace minerals Skeletal health Animal studies 

References

  1. 1.
    Copper. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. Baltimore: Lippincott Williams & Wilkins; 2012.Google Scholar
  2. 2.
    al-Rashid RA, Spangler J. Neonatal copper deficiency. N Engl J Med. 1971;285:841–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Blumenthal I, Lealman GT, Franklyn PP. Fracture of the femur, fish odour, and copper deficiency in a preterm infant. Arch Dis Child. 1980;55:229–31.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Karpel JT, Peden VH. Copper deficiency in long-term parenteral nutrition. J Pediatr. 1972;80:32–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Sutton AM, Harvie A, Cockburn F, Farquharson J, Logan RW. Copper deficiency in the preterm infant of very low birthweight. Four cases and a reference range for plasma copper. Arch Dis Child. 1985;60:644–51.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Grunebaum M, Horodniceanu C, Steinherz R. The radiographic manifestations of bone changes in copper deficiency. Pediatr Radiol. 1980;9:101–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Jonas J, Burns J, Abel EW, Cresswell MJ, Strain JJ, Paterson CR. Impaired mechanical strength of bone in experimental copper deficiency. Ann Nutr Metab. 1993;37:245–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Opsahl W, Zeronian H, Ellison M, Lewis D, Rucker RB, Riggins RS. Role of copper in collagen cross-linking and its influence on selected mechanical properties of chick bone and tendon. J Nutr. 1982;112:708–16.PubMedGoogle Scholar
  9. 9.
    Rucker RB, Riggins RS, Laughlin R, Chan MM, Chen M, Tom K. Effects of nutritional copper deficiency on the biomechanical properties of bone and arterial elastin metabolism in the chick. J Nutr. 1975;105:1062–70.PubMedGoogle Scholar
  10. 10.
    Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteoinduction and on resorption of bone particles in rats. Calcif Tissue Int. 1987;41:145–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Yee CD, Kubena KS, Walker M, Champney TH, Sampson HW. The relationship of nutritional copper to the development of postmenopausal osteoporosis in rats. Biol Trace Elem Res. 1995;48:1–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Rico H, Roca-Botran C, Hernandez ER, et al. The effect of supplemental copper on osteopenia induced by ovariectomy in rats. Menopause. 2000;7:413–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Rico H, Gomez-Raso N, Revilla M, et al. Effects on bone loss of manganese alone or with copper supplement in ovariectomized rats. A morphometric and densitomeric study. Eur J Obstet Gynecol Reprod Biol. 2000;90:97–101.PubMedCrossRefGoogle Scholar
  14. 14.
    Strain JJ. A reassessment of diet and osteoporosis–possible role for copper. Med Hypotheses. 1988;27:333–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Angus RM, Sambrook PN, Pocock NA, Eisman JA. Dietary intake and bone mineral density. Bone Miner. 1988;4:265–77.PubMedGoogle Scholar
  16. 16.
    Gaier ED, Kleppinger A, Ralle M, Mains RE, Kenny AM, Eipper BA. High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics. Exp Gerontol. 2012;47:491–6.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Baker A, Harvey L, Majask-Newman G, Fairweather-Tait S, Flynn A, Cashman K. Effect of dietary copper intakes on biochemical markers of bone metabolism in healthy adult males. Eur J Clin Nutr. 1999;53:408–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Baker A, Turley E, Bonham MP, et al. No effect of copper supplementation on biochemical markers of bone metabolism in healthy adults. Br J Nutr. 1999;82:283–90.PubMedGoogle Scholar
  19. 19.
    Cashman KD, Baker A, Ginty F, et al. No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Eur J Clin Nutr. 2001;55:525–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994;124:1060–4.PubMedGoogle Scholar
  21. 21.
    Zinc. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. Baltimore: Lippincott Williams & Wilkins; 2012.Google Scholar
  22. 22.
    Prasad AS, Miale Jr A, Farid Z, Sandstead HH, Schulert AR. Clinical and experimental. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. 1963. J Lab Clin Med. 1990;116:737–49.PubMedGoogle Scholar
  23. 23.
    Atik OS. Zinc and senile osteoporosis. J Am Geriatr Soc. 1983;31:790–1.PubMedGoogle Scholar
  24. 24.
    Gur A, Colpan L, Nas K, et al. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab. 2002;20:39–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Herzberg M, Foldes J, Steinberg R, Menczel J. Zinc excretion in osteoporotic women. J Bone Miner Res. 1990;5:251–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing. 1995;24:303–7.PubMedCrossRefGoogle Scholar
  27. 27.
    New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr. 1997;65:1831–9.PubMedGoogle Scholar
  28. 28.
    Elmstahl S, Gullberg B, Janzon L, Johnell O, Elmstahl B. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int. 1998;8:333–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Yamaguchi M. Role of nutritional zinc in the prevention of osteoporosis. Mol Cell Biochem. 2010;338:241–54.PubMedCrossRefGoogle Scholar
  30. 30.
    Ehara Y, Yamaguchi M. Zinc stimulates protein synthesis in the femoral-metaphyseal tissues of normal and skeletally unloaded rats. Res Exp Med (Berl). 1997;196:363–72.CrossRefGoogle Scholar
  31. 31.
    Yamaguchi M, Matsui R. Effect of dipicolinate, a chelator of zinc, on bone protein synthesis in tissue culture. The essential role of zinc. Biochem Pharmacol. 1989;38:4485–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Ma ZJ, Yamaguchi M. Stimulatory effect of zinc on deoxyribonucleic acid synthesis in bone growth of newborn rats: enhancement with zinc and insulin-like growth factor-I. Calcif Tissue Int. 2001;69:158–63.PubMedCrossRefGoogle Scholar
  33. 33.
    Igarashi A, Yamaguchi M. Increase in bone growth factors with healing rat fractures: the enhancing effect of zinc. Int J Mol Med. 2001;8:433–8.PubMedGoogle Scholar
  34. 34.
    Ma ZJ, Misawa H, Yamaguchi M. Stimulatory effect of zinc on insulin-like growth factor-I and transforming growth factor-beta1 production with bone growth of newborn rats. Int J Mol Med. 2001;8:623–8.PubMedGoogle Scholar
  35. 35.
    Eberle J, Schmidmayer S, Erben RG, Stangassinger M, Roth HP. Skeletal effects of zinc deficiency in growing rats. J Trace Elem Med Biol. 1999;13:21–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Fushimi H, Inoue T, Yamada Y, et al. Zinc deficiency exaggerates diabetic osteoporosis. Diabetes Res Clin Pract. 1993;20:191–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Yamaguchi M, Ehara Y. Zinc decrease and bone metabolism in the femoral-metaphyseal tissues of rats with skeletal unloading. Calcif Tissue Int. 1995;57:218–23.PubMedCrossRefGoogle Scholar
  38. 38.
    Dimai HP, Hall SL, Stilt-Coffing B, Farley JR. Skeletal response to dietary zinc in adult female mice. Calcif Tissue Int. 1998;62:309–15.PubMedCrossRefGoogle Scholar
  39. 39.
    Yamaguchi M, Yamaguchi R. Action of zinc on bone metabolism in rats. Increases in alkaline phosphatase activity and DNA content. Biochem Pharmacol. 1986;35:773–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Ovesen J, Moller-Madsen B, Thomsen JS, Danscher G, Mosekilde L. The positive effects of zinc on skeletal strength in growing rats. Bone. 2001;29:565–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Kenney MA, McCoy H. Adding zinc reduces bone strength of rats fed a low-calcium diet. Biol Trace Elem Res. 1997;58:35–41.PubMedCrossRefGoogle Scholar
  42. 42.
    Rossi L, Migliaccio S, Corsi A, et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr. 2001;131:1142–6.PubMedGoogle Scholar
  43. 43.
    Bhardwaj P, Rai DV, Garg ML. Zinc as a nutritional approach to bone loss prevention in an ovariectomized rat model. Menopause. 2013;20:1184–93.PubMedCrossRefGoogle Scholar
  44. 44.
    Norrdin RW, Krook L, Pond WG, Walker EF. Experimental zinc deficiency in weanling pigs on high and low calcium diets. Cornell Vet. 1973;63:264–90.PubMedGoogle Scholar
  45. 45.
    Leek JC, Keen CL, Vogler JB, et al. Long-term marginal zinc deprivation in rhesus monkeys. IV. Effects on skeletal growth and mineralization. Am J Clin Nutr. 1988;47:889–95.PubMedGoogle Scholar
  46. 46.
    Freudenheim JL, Johnson NE, Smith EL. Relationships between usual nutrient intake and bone-mineral content of women 35–65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr. 1986;44:863–76.PubMedGoogle Scholar
  47. 47.
    Peretz A, Papadopoulos T, Willems D, et al. Zinc supplementation increases bone alkaline phosphatase in healthy men. J Trace Elem Med Biol. 2001;15:175–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Nielsen FH, Lukaski HC, Johnson LK, Roughead ZK. Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women. Br J Nutr. 2011;106:1872–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Sheng MH, Taper LJ, Veit H, Thomas EA, Ritchey SJ, Lau KH. Dietary boron supplementation enhances the effects of estrogen on bone mineral balance in ovariectomized rats. Biol Trace Elem Res. 2001;81:29–45.PubMedCrossRefGoogle Scholar
  50. 50.
    Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res. 1998;66:319–30.PubMedCrossRefGoogle Scholar
  51. 51.
    Rico H, Crespo E, Hernandez ER, Seco C, Crespo R. Influence of boron supplementation on vertebral and femoral bone mass in rats on strenuous treadmill exercise. A morphometric, densitometric, and histomorphometric study. J Clin Densitom. 2002;5:187–92.PubMedCrossRefGoogle Scholar
  52. 52.
    Kaats GR, Preuss HG, Croft HA, Keith SC, Keith PL. A comparative effectiveness study of bone density changes in women over 40 following three bone health plans containing variations of the same novel plant-sourced calcium. Int J Med Sci. 2011;8:180–91.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Michalek JE, Preuss HG, Croft HA, et al. Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study. Nutr J. 2011;10:32.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Hooshmand S, Chai SC, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH. Comparative effects of dried plum and dried apple on bone in postmenopausal women. Br J Nutr. 2011;106:923–30.PubMedCrossRefGoogle Scholar
  55. 55.
    Dijkgraaf-Ten Bolscher M, Netelenbos JC, Barto R, van Der Vijgh WJ. Strontium as a marker for intestinal calcium absorption: the stimulatory effect of calcitriol. Clin Chem. 2000;46:248–51.PubMedGoogle Scholar
  56. 56.
    Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int. 2001;69:121–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Marie PJ, Hott M, Modrowski D, et al. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res. 1993;8:607–15.PubMedCrossRefGoogle Scholar
  58. 58.
    Dahl SG, Allain P, Marie PJ, et al. Incorporation and distribution of strontium in bone. Bone. 2001;28:446–53.PubMedCrossRefGoogle Scholar
  59. 59.
    Delannoy P, Bazot D, Marie PJ. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism. 2002;51:906–11.PubMedCrossRefGoogle Scholar
  60. 60.
    Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350:459–68.PubMedCrossRefGoogle Scholar
  61. 61.
    Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90:2816–22.PubMedCrossRefGoogle Scholar
  62. 62.
    Reginster JY, Felsenberg D, Boonen S, et al. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum. 2008;58:1687–95.PubMedCrossRefGoogle Scholar
  63. 63.
    Kaufman JM, Audran M, Bianchi G, et al. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab. 2013;98:592–601.PubMedCrossRefGoogle Scholar
  64. 64.
    Cooper C, Reginster JY, Cortet B, et al. Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Curr Med Res Opin. 2012;28:475–91.PubMedCrossRefGoogle Scholar
  65. 65.
    Audran M, Jakob FJ, Palacios S, et al. A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years. Rheumatol Int. 2013;33:2231–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Das S, Crockett JC. Osteoporosis—a current view of pharmacological prevention and treatment. Drug Des Devel Ther. 2013;7:435–48.PubMedCentralPubMedGoogle Scholar
  67. 67.
    Kim MH, Bae YJ, Choi MK, Chung YS. Silicon supplementation improves the bone mineral density of calcium-deficient ovariectomized rats by reducing bone resorption. Biol Trace Elem Res. 2009;128:239–47.PubMedCrossRefGoogle Scholar
  68. 68.
    Bae YJ, Kim JY, Choi MK, Chung YS, Kim MH. Short-term administration of water-soluble silicon improves mineral density of the femur and tibia in ovariectomized rats. Biol Trace Elem Res. 2008;124:157–63.PubMedCrossRefGoogle Scholar
  69. 69.
    Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res. 1993;6:247–9.PubMedGoogle Scholar
  70. 70.
    Jugdaohsingh R, Tucker KL, Qiao N, Cupples LA, Kiel DP, Powell JJ. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Miner Res. 2004;19:297–307.PubMedCrossRefGoogle Scholar
  71. 71.
    Macdonald HM, Hardcastle AC, Jugdaohsingh R, Fraser WD, Reid DM, Powell JJ. Dietary silicon interacts with oestrogen to influence bone health: evidence from the Aberdeen Prospective Osteoporosis Screening Study. Bone. 2012;50:681–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Ghanizadeh G, Babaei M, Naghii MR, Mofid M, Torkaman G, Hedayati M. The effect of supplementation of calcium, vitamin D, boron, and increased fluoride intake on bone mechanical properties and metabolic hormones in rat. Toxicol Ind Health. 2012;30:211–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr. 2006;46:621–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322:802–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Meunier PJ, Sebert JL, Reginster JY, et al. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int. 1998;8:4–12.PubMedCrossRefGoogle Scholar
  76. 76.
    Reginster JY, Meurmans L, Zegels B, et al. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial. Ann Intern Med. 1998;129:1–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Ringe JD, Kipshoven C, Coster A, Umbach R. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate. Osteoporos Int. 1999;9:171–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Grey A, Garg S, Dray M, et al. Low-dose fluoride in postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab. 2013;98:2301–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Rico H, Gallego-Lago JL, Hernandez ER, et al. Effect of silicon supplement on osteopenia induced by ovariectomy in rats. Calcif Tissue Int. 2000;66:53–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of PediatricsUC Davis Children’s HospitalSacramentoUSA

Personalised recommendations